COO

The Cooper Companies, Inc. NASDAQ

Healthcare ·Medical - Instruments & Supplies ·US · coopercos.com

$61.52

Mkt Cap $12.0B

52w Low $60.64 3.0% of range 52w High $89.83

50d MA $72.37 200d MA $74.17

P/E (TTM) 33.2x

EV/EBITDA 15.8x

P/B 1.5x

Debt/Equity 0.3x

ROE 4.8%

P/FCF 32.2x

RSI (14) —

ATR (14) —

Beta 1.07

50d MA $72.37

200d MA $74.17

Avg Volume 2.0M

About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presby…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Mar 5, 2026	AMC	1.03	1.10	+6.8%	80.20	-4.0%	-4.6%	-5.5%	-7.2%	-8.0%	-10.8%	-12.4%	—
Dec 4, 2025	AMC	1.11	1.15	+3.6%	77.03	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%	+7.4%	—
Aug 27, 2025	AMC	1.07	1.10	+2.8%	74.11	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%	-8.9%	—
May 29, 2025	AMC	0.93	0.96	+3.4%	79.96	-10.0%	-14.6%	-16.2%	-16.3%	-15.7%	-11.0%	-11.0%	—
Mar 6, 2025	AMC	0.91	0.92	+0.7%	90.98	-5.3%	-6.6%	-12.2%	-10.9%	-13.1%	-14.6%	-19.4%	—
Dec 5, 2024	AMC	1.00	1.04	+4.0%	103.23	-3.7%	-4.4%	-3.8%	-4.0%	-3.8%	-6.3%	-9.9%	—
Aug 28, 2024	AMC	0.91	0.96	+5.4%	94.54	+10.1%	+11.8%	+11.8%	+12.2%	+11.6%	+12.7%	+16.1%	—
May 30, 2024	AMC	0.83	0.85	+2.5%	90.23	+6.4%	+4.5%	+5.0%	+4.8%	+4.4%	+5.6%	-4.3%	—
Feb 29, 2024	AMC	0.78	0.85	+8.6%	93.60	+9.0%	+9.2%	+9.8%	+8.4%	+8.8%	+9.1%	+6.0%	—
Dec 7, 2023	AMC	0.87	0.87	+0.0%	86.24	-0.3%	-2.9%	-1.6%	-1.4%	+3.1%	+6.5%	+8.3%	—
Aug 30, 2023	AMC	0.84	0.84	+0.0%	95.21	-0.7%	-2.8%	-4.2%	-7.5%	-6.4%	-7.1%	-16.5%	—
Jun 1, 2023	AMC	0.75	0.77	+2.7%	93.55	-3.8%	-4.7%	-5.5%	-5.8%	-6.3%	-6.5%	+0.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 6	Citigroup	Maintains	Neutral → Neutral	—	$80.20	$77.00	-4.0%	-4.6%	-5.5%	-7.2%	-8.0%	-10.8%
Mar 6	Needham	Maintains	Buy → Buy	—	$80.20	$77.00	-4.0%	-4.6%	-5.5%	-7.2%	-8.0%	-10.8%
Mar 6	Barclays	Maintains	Overweight → Overweight	—	$80.20	$77.00	-4.0%	-4.6%	-5.5%	-7.2%	-8.0%	-10.8%
Feb 3	Needham	Maintains	Buy → Buy	—	$80.65	$80.39	-0.3%	-1.6%	+0.3%	-0.7%	+1.8%	+1.0%
Jan 26	Barclays	Maintains	Overweight → Overweight	—	$81.29	$81.52	+0.3%	-0.5%	-0.7%	-1.0%	-1.1%	+0.1%
Dec 8	Citigroup	Maintains	Neutral → Neutral	—	$81.40	$81.70	+0.4%	-4.1%	-3.6%	-0.8%	+0.9%	+0.8%
Dec 8	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$81.40	$81.70	+0.4%	-4.1%	-3.6%	-0.8%	+0.9%	+0.8%
Dec 8	Goldman Sachs	Maintains	Sell → Sell	—	$81.40	$81.70	+0.4%	-4.1%	-3.6%	-0.8%	+0.9%	+0.8%
Dec 5	JP Morgan	Maintains	Neutral → Neutral	—	$77.03	$89.66	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%
Dec 5	Mizuho	Maintains	Outperform → Outperform	—	$77.03	$89.66	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%
Dec 5	Piper Sandler	Maintains	Overweight → Overweight	—	$77.03	$89.66	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%
Dec 5	Baird	Maintains	Outperform → Outperform	—	$77.03	$89.66	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%
Dec 5	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$77.03	$89.66	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%
Dec 5	Needham	Maintains	Buy → Buy	—	$77.03	$89.66	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%
Dec 5	Stifel	Maintains	Buy → Buy	—	$77.03	$89.66	+16.4%	+5.7%	+1.3%	+1.9%	+4.8%	+6.6%
Nov 13	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$72.49	$71.43	-1.5%	-1.0%	-0.5%	-1.6%	-0.4%	-0.5%
Aug 28	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Aug 28	Wells Fargo	Maintains	Overweight → Overweight	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Aug 28	Citigroup	Downgrade	Buy → Neutral	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Aug 28	Stifel	Maintains	Buy → Buy	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Aug 28	Needham	Maintains	Buy → Buy	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Aug 28	Piper Sandler	Maintains	Overweight → Overweight	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Aug 28	JP Morgan	Maintains	Neutral → Neutral	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Aug 28	Baird	Maintains	Outperform → Outperform	—	$74.11	$62.27	-16.0%	-12.9%	-9.1%	-11.8%	-9.4%	-8.2%
Jul 16	Mizuho	Maintains	Outperform → Outperform	—	$72.20	$73.10	+1.2%	+0.7%	+1.5%	+0.6%	-1.2%	+1.1%
Jun 17	Needham	Upgrade	Hold → Buy	—	$69.74	$70.34	+0.9%	-1.4%	+0.1%	-0.4%	-0.3%	+1.7%
May 30	Baird	Maintains	Outperform → Outperform	—	$79.96	$71.98	-10.0%	-14.6%	-16.2%	-16.3%	-15.7%	-11.0%
May 30	Wells Fargo	Maintains	Overweight → Overweight	—	$79.96	$71.98	-10.0%	-14.6%	-16.2%	-16.3%	-15.7%	-11.0%
May 30	Piper Sandler	Maintains	Overweight → Overweight	—	$79.96	$71.98	-10.0%	-14.6%	-16.2%	-16.3%	-15.7%	-11.0%
May 30	Needham	Maintains	Hold → Hold	—	$79.96	$71.98	-10.0%	-14.6%	-16.2%	-16.3%	-15.7%	-11.0%
May 30	JP Morgan	Downgrade	Overweight → Neutral	—	$79.96	$71.98	-10.0%	-14.6%	-16.2%	-16.3%	-15.7%	-11.0%
May 22	Needham	Maintains	Hold → Hold	—	$79.37	$79.37	+0.0%	-0.1%	-0.7%	+1.5%	+0.9%	+0.7%
Mar 7	Baird	Maintains	Outperform → Outperform	—	$90.98	$86.18	-5.3%	-6.6%	-12.2%	-10.9%	-13.1%	-14.6%
Mar 7	Stifel	Maintains	Buy → Buy	—	$90.98	$86.18	-5.3%	-6.6%	-12.2%	-10.9%	-13.1%	-14.6%
Mar 7	Citigroup	Maintains	Buy → Buy	—	$90.98	$86.18	-5.3%	-6.6%	-12.2%	-10.9%	-13.1%	-14.6%
Mar 7	JP Morgan	Maintains	Overweight → Overweight	—	$90.98	$86.18	-5.3%	-6.6%	-12.2%	-10.9%	-13.1%	-14.6%
Mar 7	Needham	Maintains	Hold → Hold	—	$90.98	$86.18	-5.3%	-6.6%	-12.2%	-10.9%	-13.1%	-14.6%
Mar 7	Piper Sandler	Maintains	Overweight → Overweight	—	$90.98	$86.18	-5.3%	-6.6%	-12.2%	-10.9%	-13.1%	-14.6%
Dec 6	Needham	Maintains	Hold → Hold	—	$103.23	$99.39	-3.7%	-4.4%	-3.8%	-4.0%	-3.8%	-6.3%
Dec 6	Citigroup	Maintains	Buy → Buy	—	$103.23	$99.39	-3.7%	-4.4%	-3.8%	-4.0%	-3.8%	-6.3%
Dec 6	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$103.23	$99.39	-3.7%	-4.4%	-3.8%	-4.0%	-3.8%	-6.3%
Dec 6	Wells Fargo	Maintains	Overweight → Overweight	—	$103.23	$99.39	-3.7%	-4.4%	-3.8%	-4.0%	-3.8%	-6.3%
Mar 13	JP Morgan	Upgrade	Neutral → Overweight	—	$101.54	$103.50	+1.9%	+0.8%	-0.0%	-0.8%	-0.7%	+0.7%
Mar 1	JP Morgan	Maintains	Neutral → Neutral	—	$93.60	$102.04	+9.0%	+9.2%	+9.8%	+8.4%	+8.8%	+9.1%
Mar 1	Mizuho	Maintains	Buy → Buy	—	$93.60	$102.04	+9.0%	+9.2%	+9.8%	+8.4%	+8.8%	+9.1%
Mar 1	Stifel	Maintains	Buy → Buy	—	$93.60	$102.04	+9.0%	+9.2%	+9.8%	+8.4%	+8.8%	+9.1%
Mar 1	Piper Sandler	Maintains	Overweight → Overweight	—	$93.60	$102.04	+9.0%	+9.2%	+9.8%	+8.4%	+8.8%	+9.1%
Jan 12	Piper Sandler	Maintains	Overweight → Overweight	—	$95.13	$96.08	+1.0%	+0.9%	+0.6%	-0.5%	+1.4%	+1.8%
Dec 4	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$85.27	$84.61	-0.8%	-0.8%	-1.7%	+0.4%	+1.1%	-1.8%
Nov 29	JP Morgan	Maintains	Neutral → Neutral	—	$83.58	$83.74	+0.2%	-0.8%	+0.8%	+2.0%	+1.2%	+0.3%

Recent Filings

8-K · 5.02 !!! Very High

The Cooper Companies, Inc. -- 8-K 5.02: Executive Change

Paul Keel's appointment as an independent director at Cooper Companies strengthens the company's board oversight and governance structure.

May 4

8-K

Unknown — 8-K Filing

I cannot provide a meaningful analysis because the filing summary provided is incomplete and contains only technical metadata rather than substantive business information about Cooper-Standard Holdings or the actual 8-K content.

Apr 8

8-K

The Cooper Companies, Inc. -- 8-K Filing

Cooper Companies reported Q1 2026 revenue of $1.024 billion, up 6% year-over-year (3% organic growth), demonstrating modest but steady expansion in its medical device business.

Mar 5

8-K

The Cooper Companies, Inc. -- 8-K Filing

Cooper Companies amended its 2024 Credit Agreement to align provisions with its 2021 Loan Agreement and eliminate credit spread adjustments, streamlining its debt structure.

Feb 4

Data updated apr 25, 2026 2:38am · Source: massive.com